Journal Pre-proof Tuning the surface immunomodulatory functions of polyetheretherketone for enhanced osseointegration Ang Gao, Qing Liao, Lingxia Xie, Guomin Wang, Wei Zhang, Yuzheng Wu, Penghui Li, Min Guan, Haobo Pan, Liping Tong, Paul K. Chu, Huaiyu Wang PII:
S0142-9612(19)30741-0
DOI:
https://doi.org/10.1016/j.biomaterials.2019.119642
Reference:
JBMT 119642
To appear in:
Biomaterials
Received Date: 9 August 2019 Revised Date:
14 November 2019
Accepted Date: 19 November 2019
Please cite this article as: Gao A, Liao Q, Xie L, Wang G, Zhang W, Wu Y, Li P, Guan M, Pan H, Tong L, Chu PK, Wang H, Tuning the surface immunomodulatory functions of polyetheretherketone for enhanced osseointegration, Biomaterials (2019), doi: https://doi.org/10.1016/j.biomaterials.2019.119642. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2019 Published by Elsevier Ltd.
Tuning the Surface Immunomodulatory Functions of Polyetheretherketone for Enhanced Osseointegration
Ang Gaoa,b, Qing Liaoa, Lingxia Xiea, Guomin Wangb, Wei Zhangc, Yuzheng Wua, Penghui Lia,b, Min Guana, Haobo Pana, Liping Tonga,*, Paul K. Chub,*, Huaiyu Wanga,*
a
Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology,
Chinese Academy of Science, Shenzhen 518055, China b
Department of Physics, Department of Materials Science and Engineering, and Department
of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Hong Kong, China c
Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190,
China
* Corresponding authors E-mail addresses:
[email protected] (Liping Tong),
[email protected] (Paul K. Chu),
[email protected] (Huaiyu Wang)
1
Abstract The adverse macrophage-mediated immune response elicited by the surface of polyetheretherketone (PEEK) is responsible for the formation of fibrous encapsulation and resulting inferior osseointegration of PEEK implants in the dental and orthopedic fields. Therefore, endowing the PEEK surface with immunomodulatory ability is an appealing strategy to enhance implant-bone integration.
Herein, a reliable and cost-effective method to
construct adherent films with tunable nanoporous structures on PEEK is described.
The
functionalized surface not only suppresses the acute inflammatory response of macrophages, but also provides a favorable milieu for osteogenic differentiation of human bone marrow mesenchymal stem cells (hBMSCs).
Whole genome expression analysis reveals that the
suppression effect arises from synergistic inhibition of focal adhesion, Toll-like receptor, and NOD-like receptor signaling pathways, as well as the attenuating loop through the JAK-STAT and TNF signaling pathways in macrophages.
Further in vivo studies confirm
that the functionalized surface induces less fibrous capsule formation and an improved bone regeneration.
The nanoporous films fabricated on PEEK harmonize the early
macrophage-mediated inflammatory response and subsequent hBMSCs-centered osteogenic functions consequently yielding superior osseointegration.
Keywords: immunomodulation, polyetheretherketone, osseointegration, surface modification, orthopedic implants
2
1. Introduction
As promising alternative materials to conventional metals used in dental and orthopedic implants, polyetheretherketone (PEEK) possess superior characteristics including the excellent mechanical properties, good chemical stability and biocompatibility, as well as natural radiolucency [1,2].
Moreover, the elastic modulus of PEEK is less than those of
metals and comparable to that of cortical bone.
This attribute alleviates the stress shielding
effect plaguing metallic implants thus avoiding peri-implant bone resorption, loosening and even failure of implants [1,3].
However, PEEK implants still suffer from the inherent
bioinertness which severely impedes integration with bone tissues [4, 5].
Up to now,
considerable efforts have been made to functionalize the PEEK surface, for instance, sulfonation in concentrated sulfuric acid [6,7], deposition of silicate coatings by electron beam evaporation [8], and surface fluorination by plasma treatment [9].
Previous studies
have mainly focused on the osteoblastic lineage cells that enhance osteogenesis, but the host immune response crucial to the long-term survival and performance of implants has seldom been investigated and the related mechanisms are not well understood. After implantation of biomaterials in vivo, a cascade of inflammatory responses is initiated by immune cells [10].
Among the various immune cells, macrophages play a
central role in orchestrating the host immune response by releasing a repertoire of cytokines and growth factors to determine the fate of biomaterials [11,12].
Macrophages exhibit a
wide spectrum of polarization states which can be categorized into the pro-inflammatory M1 phenotype and anti-inflammatory, healing-related M2 phenotype [13].
3
Generally,
macrophages persist in the pro-inflammatory M1 phenotype on the PEEK surface, leading to fusion of macrophages into multinucleated giant cells with increased release in fibrosis-enhancing cytokine.
These molecular signals thereafter contribute to the formation
of fibrous encapsulation and inferior osseointegration [14].
In contrast, transient and
appropriate inflammatory responses (M1 polarization) followed by the timely switch to the M2 phenotype, which releases cytokines and chemokines to resolve inflammation, recruit osteoprogenitor cells, and activate osteogenesis, will contribute to superior osseointegration of the implants [15].
In this respect, functionalization of the PEEK surface with the
immunomodulatory ability to provide a favorable osteo-immune environment is highly desirable. Several strategies have been proposed to modulate the inflammatory response elicited by implanted biomaterials [16].
For example, local delivery of interleukin-4 (IL-4)
cytokines from the surface has been applied to promote macrophage polarization towards the M2 phenotype [17].
The “marker of self” CD47 protein is covalently immobilized on the
surface to shield the implant from recognition by the host immune system [18].
However,
these strategies suffer from drawbacks such as the complicated preparation procedures, high cost of recombinant proteins, as well as short product shelf-life.
In fact, the physical
properties, particularly the surface topography of biomaterials, are increasingly recognized as a robust cue to regulate various cell functions.
Specifically, topographical cues have been
shown to modulate the immune response by selectively polarizing macrophages [19].
For
instance, the surface nanotopography mitigates the activation of macrophages, leading to decreased secretion of pro-inflammatory cytokines [20,21].
4
On the other hand, surface
nanostructures with different features can be used to precisely guide the differentiation of bone mesenchymal stem cells into osteogenic lineage [22].
Many examples are available in
orthopedic and dental applications where titanium is widely used, as the nanotube arrays can be easily fabricated on titanium-based implants by electrochemical anodization [23,24]. With regard to PEEK, strategies such as sandblasting [25], porogen leaching [26], and plasma immersion ion implantation [27] have been proposed to enhance osseointegration via surface roughening.
However, PEEK is quite inert rendering surface functionalization difficult and
few studies have focused on the inflammatory responses. As an effective technique involving the electrostatic interactions between oppositely charged species [28], layer-by-layer (LBL) self-assembly has been adopted.
By dipping in
solutions of complementary polyelectrolytes successively, multilayered films with tailored chemical compositions and architectures can be constructed [29].
In fact, LBL films have
been fabricated on different types of biomaterials for drug delivery [30], gene therapy [31], anti-biofouling/antibacterial resistance [32, 33], as well as mediation of cellular functions [34]. In this study, this reliable and cost-effective technique is implemented to render PEEK with the immunomodulatory ability in additon to better osteogenesis and subsequent osseointegration. In this work, the LBL self-assembly technique is employed to fabricate adherent films with tunable nanoscale porosity on PEEK.
The in vitro acute inflammatory response of
macrophages and osteogenic performance of human bone marrow mesenchymal stem cells (hBMSCs) cultured on the modified surfaces are investigated systematically and in vivo experiments are carried out on rat femurs bone to verify the osseointegration ability.
5
In
addition, whole genome expression analysis is performed to elucidate the underlying mechanisms why macrophages respond differently on the modified surface.
2. Materials and Methods
2.1 Materials
The poly(acrylic acid) solution (PAA; average molecular weight ~100,000, 35 wt.% in H2O), 2-mercaptoethanol, phorbol-12-myristate-13-acetate (PMA), lipopolysaccharides (from Escherichia coli), ascorbic acid 2 phosphate, β-glycerophosphate, and dexamethasone were purchased from Sigma-Aldrich.
Poly(allylamine hydrochloride) (PAH; average molecular
weight 120,000 ~ 200,000) was obtained from Alfa Aesar.
Water purified by the Milli-Q
water system (Millipore) was used in the experiments and the other reagents were obained from Sigma-Aldrich unless stated otherwise.
2.2 Surface preparation
Medical grade PEEK rods were supplied by GEHR Plastics Inc. (Mannheim, Germany) and cut into pieces with dimensions of Φ 15 mm × 2 mm.
The samples were ground with
sandpapers progressively up to 2000 grits, ultrasonically cleaned with acetone, ethanol, and deionized water, dried with nitrogen (N2) flow, and used as the PEEK control.
The pristine
PEEK underwent O2 plasma treatment at 150 W and 100 Pa for 2 minutes in a plasma cleaner (PT-10s, Potentlube, Shenzhen, China) and the sample was denoted O2.
The polyelectrolyte
multilayered films of PAH and PAA were deposited on the O2 samples by the LBL technique. 6
Both polyelectrolytes were prepared with a concentration of 0.01 M (based on the repeat unit of the polymer) in an aqueous solution.
The pH of PAH and PAA was adjusted with 0.1 M
sodium hydroxide (NaOH) or hydrochloric acid (HCl) to be 8.5 and 3.5, respectively.
The
LBL-assembled PAH/PAA films were fabricated by alternately dipping the O2 samples into aqueous PAH and PAA for 1 minute in each solution, followed by gentle agitation in deionized water each time.
The procedures were repeated until a total of 21 layers were
deposited with both the first and last layer being PAH.
Afterwards, the samples were rinsed
with the pH1.8 solution for 30 seconds followed by immersion in deionized water for 30 seconds or rinsed with a pH2.4 solution for 30 seconds.
The wet films were blown dry with
high-purity N2 and introduced into an oven at 180 °C for 2 hours.
The samples were denoted
as PH1.8 and PH2.4 and the processing procedures are schematically illustrated in Fig. 1.
Fig. 1.
Schematic illustration of the sample processing procedures.
treated with an O2 plasma for 2 minutes.
The pristine PEEK is
Afterwards, polyelectrolyte multilayers of PAH
and PAA are deposited by dipping the samples successively into the aqueous PAH and PAA for 1 minute each, followed by gentle agitation in deionized water each time.
7
The process
was repeated until a total of 21 layers are deposited and the first and last layers are PAH. Afterwards, different nanoporous topographies are constructed by either rinsing with the pH1.8 solution for 30 seconds followed by immersion in deionized water for 30 seconds or rinsing with the pH2.4 solution for 30 seconds. cross-linking at 180 °C for 2 hours.
The nanostructures are produced by thermal
The sample designations are underlined.
2.3 Sample characterization
The surface morphology was observed by field-emission scanning electron microscopy (FE-SEM; Supra 55, Zeiss, Germany) after the specimens were dried and sputter-coated with platinum.
The surface topography and roughness were determined by atomic force
microscopy (AFM; NanoScope V MultiMode 8 system, Bruker, Germany) performed on an area of 5 µm × 5 µm.
The surface chemical states were determined by X-ray photoelectron
spectroscopy (XPS; Escalab 250Xi, Thermo Fisher, USA).
The surface hydrophilicity was
measured with 5 µl of distilled water by the sessile drop method on the Rame'-Hart instrument (USA) under ambient conditions.
The surface zeta potential was measured on the Surpass
electrokinetic analyzer (Anton Parr, Austria).
A 0.001 M potassium chloride (KCl) solution
was used as the medium and the pH was adjusted in the range between 4.0 and 10.0 by HCl or NaOH.
In the electrical measurements, the electrolyte solution flowed on the sample surface
and the potential resulting from the motion of ions in the diffusion layer was determined according to the following Helmholtze-Smoluchowski equation: ζ =
× × ×
8
where ζ is the zeta potential, dI/dP represents the slope of the streaming current versus pressure difference, η, ε, and ε0 denote the viscosity, dielectric constant, and vacuum permittivity of the electrolyte, respectively, and L and A are the length and cross-section of the streaming channel, respectively.
2.4 Nano-scratch test
The nano-scratch test was carried out to assess the adhesion strength of the multilayered films on different substrates.
The PEEK substrates were polished to a mirror finish before
film fabrication to alleviate the influence of surface roughness.
The test was performed on
the Keysight Nano Indenter G200 equipped with a cube corner indenter tip.
The indenter
was drawn across the sample surface using a ramp loading setup from 0 mN to 10 mN at a constant scratch velocity of 0.5 µm/s.
A total scratch length of 50 µm was generated and
three scratches were performed on each samples.
The fractures were observed by SEM after
sputter-coating with platinum.
2.5 Acute inflammation response of RAW264.7 2.5.1 Cell culture
The murine-derived macrophage cell line RAW264.7 was obtained from the American Type Culture Collection (ATCC) and used as the cell model to evaluate the acute inflammatory response to the samples.
The cells were maintained in the high-glucose
dulbecco's modified eagle medium (DMEM, Hyclone) supplemented with 10% fetal bovine serum (FBS; Corning) and 1% penicillin-streptomycin (Invitrogen) at 37 °C in humidified 5%
9
CO2 incubator.
Unless otherwise stated, the cells were seeded onto different samples with
an initial density of 1 × 105 cells/well on 24-well tissue culture plates (TCP) as holders.
The
TCP wells and TCP wells added with 10 ng/ml lipopolysaccharides in medium served as the negative and positive controls, respectively.
2.5.2 Cell morphology and proliferation After seeding 2 × 104 cells and incubating for 24 hours, the morphology of cells was examined by FE-SEM.
Prior to FE-SEM observation, the cells were fixed with 2.5%
glutaraldehyde, dehydrated through a graded ethanol series, critical-point dried, and sputter-coated with platinum.
Proliferation of RAW264.7 after culturing for 1 and 3 days
was determined by the CCK-8 (Donjindo, Japan) assay.
At each time point, the medium was
refreshed with the serum-free medium containing 10% CCK-8 and incubated at 37 °C for 4 hours.
Subsequently, the supernatant with a volume of 100 µl was collected and the
absorbance was determined on a microplate reader at a wavelength of 450 nm.
2.5.3 Polarization of macrophages
The expression of M1- and M2-related genes was analyzed by the real-time polymerase chain reaction (RT-PCR).
After RAW264.7 had been seeded on the different samples for 1,
3, and 5 days, the total RNA was extracted from the cultured cells by TRIzol Reagent (Invitrogen, USA).
The RNA was then reversely transcribed into complementary DNA
(cDNA) using a RevertAid First Strand cDNA Synthesis Kit (Thermo Fisher) following the manufacturer’s instruction.
The expressions of M1-related genes including inducible nitric
oxide synthase (iNOS), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), interleukin 1 10
beta (IL-1β), and M2-related genes such as the mannose receptor (CD206), transforming growth factor beta 1 (TGF-β1), bone morphogenetic protein 2 (BMP-2), and vascular endothelial growth factor (VEGF) were analyzed by RT-PCR on the Bio-Rad CFX 96 Real-Time System using a mixture of SYBRGreen Realtime PCR Master Mix (Transgen Biotech, China), as well as the forward and reverse primers listed in Table S1.
The relative
gene expression levels were calculated using the 2-∆∆Ct method with the mean threshold cycle (Ct) values normalized to the house-keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
2.5.4 Determination of TNF-α secretion
The level of TNF-α released by RAW264.7 after culturing for 3 days was quantified by the enzyme-linked immunosorbent assay (ELISA) using a commercial kit (DuoSet, R&D systems, USA) according to the manufacturer’s instructions.
Briefly, a goat anti-mouse
TNF-α capture antibody was pre-coated on the bottom of a 96-well plate and the supernatant was pipetted into the wells and incubated at room temperature for 2 hours.
Each well was
sequentially incubated with the biotinylated goat anti-Mouse TNF-α detection antibody for 2 hours, horseradish-peroxidase conjugated streptavidin solution for 20 minutes, and substrate solution (1:1 mixture of H2O2 and tetramethylbenzidine) for 20 minutes.
After adding Stop
Solution (2 N of H2SO4), the absorbance was monitored on a microplate spectrophotometer at 450 nm.
The amount of released TNF-α was calculated according to the standard curve of
TNF-α and then normalized to the DNA content in the cell lysate as pg/µg DNA. The
DNA content
was
determined
11
by
adding
4’,6-Diamidino-2-phenylindole
dihydrochloride (DAPI), a specific and sensitive fluorescing DNA stain, to the cell lysate at a concentration of 0.5 µg/ml.
The fluorescent signals were detected by a spectrofluorometer
(MD Gemini EM, Molecular Devices, USA) with excitation at 365 nm and emission at 460 nm.
The concentration of DNA was calculated according to the standard curve established
by different concentrations of salmon DNA.
2.5.5 TRAP activity
To evaluate osteoclastic differentiation of RAW264.7 after culturing for 8 days, the intracellular tartrate-resistant acid phosphatase (TRAP) activity was determined quantitatively using a commercial TRAP Assay Kit (Beyotime, China) following the manufacturer‘s protocol.
The results were normalized to the total intracellular protein content determined
by the bicinchoninic acid (BCA) Protein Assay Kit (Pierce, Thermo Fisher, USA) and expressed as nmol/min/mg protein.
2.5.6 Determination of NO production and intracellular ROS content
The relative content of nitric oxide (NO) in the cell culture supernatant after incubating RAW264.7 on different samples for 3 days was quantitatively determined using the Total NO Assay Kit (Beyotime, China).
The intracellular reactive oxygen species (ROS) was
evaluated by the cell-permeant fluorescence probe dichlorofluorescin diacetate (DCFH-DA) provided by the ROS Assay Kit (Beyotime, China).
Briefly, the cells incubated for 3 days
were rinsed with PBS and incubated with 10 µM DCFH-DA for 30 minutes at 37 °C in darkness.
After diffusion into cells, DCFH-DA was deacetylated by cellular esterases to a
nonfluorescent compound which was later oxidized by intracellular ROS into a highly 12
fluorescent compound dichlorofluorescein.
The cells on the samples were detached, washed,
and resuspended in the PBS solution for flow cytometry analysis of over 10,000 cells on a BD Bioscience Canto II System.
The cells cultured on TCP were treated with Rosup (ROS
inducer provided by the ROS Assay Kit) as the positive control.
2.6 Whole genome expression analysis
The whole genome expression analysis was carried out after culturing the RAW264.7 cells on the PEEK and PH1.8 samples in triplicate for 3 days.
The total RNA was extracted
from the cells using Trizol reagent (Life Technologies, USA) followed by purification with the RNeasy Mini Kit (Qiagen, USA).
The double-stranded cDNA was synthesized from the
total RNA using primers containing a T7 promoter sequence and then converted into cRNA by in vitro transcription.
After purification, the cRNA was again reverse-transcribed into
sense-strand cDNA which was subsequently fragmented and hybridized to Mouse Clariom® S Array (Affymetrix, USA).
Afterwards, the gene chips were washed and stained in the
GeneChip Fluidics Station 450 (Affymetrix, USA).
All the arrays were scanned by the
GeneChip Scanner 3000 7G (Affymetrix, USA) equipped with the Affymetrix® GeneChip Command Console (Affymetrix, USA). protocols provided by Affymetrix.
All the procedures were performed according to the
The expression values were normalized using the Robust
Multiarray Average (RMA) algorithm and log2-transformed.
The differentially expressed
genes were defined by a fold change (FC) > 1.3 or < -1.3 and a false discovery rate-corrected p < 0.05 identified based on the student’s t-test for comparison of PH1.8 with the PEEK control.
13
To elucidate the biological implications of the differentially expressed genes, gene ontology (GO) analysis was performed and the enriched terms were identified using the Fisher’s exact test.
Pathway analysis were also carried out to identify the significant
pathways of the differential genes according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database.
The pathway-act network was constructed based on the KEGG
database to reveal the interaction among these significant enriched pathways.
The degree
centrality was defined as the number of links to upstream and downstream pathways, which were shown as in-degree and out-degree, respectively.
A higher degree indicates that the
pathway has a strong correlation with the other one implying a more important role in the signaling network.
The experimental design and data analysis in the whole genome
expression analysis are described in the flow chart in Fig. S1.
2.7 Effects of macrophage-conditioned medium on hBMSCs
The human monocytic THP-1 cells obtained from ATCC were cultured in the RPMI 1640
medium
(Hyclone)
supplemented
with
10%
FBS
2-mercaptoethanol, and 1% penicillin-streptomycin (Invitrogen).
(Corning),
0.05
mM
The cells were seeded on
differnt samples with an initial density of 3 × 105 cells/well using 24-well TCP as the holders and maintained under 5% CO2 at 37 °C.
The THP-1 monocytes were induced to
differentiate into macrophages after incubation for 48 h with 160 nM PMA in RPMI 1640 medium, followed by immersion in the PMA-free α-minimum essential medium (αMEM, Hyclone) for another day. surfaces and spread.
Upon differentiation, the suspended THP-1 cells attached to the
The TNF-α production levels in the culture supernatants were assessed
14
using a commercial ELISA Kit (Human TNF-Alpha valukine ELISA, R&D systems, USA) following the kit protocols. The monocyte-derived macrophages conditioned medium was prepared by maintaining the induced macrophages in αMEM (Hyclone) for 24 hours.
The conditioned medium was
collected, centrifuged, and frozen at -80 °C for further use.
Following incubation of
hBMSCs in the 24-well TCP for 4 days, the medium was replaced by the macrophage conditioned medium supplemented with 50 µg/ml ascorbic acid 2 phosphate, 10 mM β-glycerophosphate, and 10 nM dexamethasone for osteogenic induction.
The conditioned
medium was collected everyday and supplied to hBMSCs every 2 days for a total of 7 days. The intracellular alkaline phosphatase (ALP) activities in the cell lysis were quantitatively assayed on day 3 and day 7 using an ALP Assay Kit (Beyotime, China) according to the procedure recommended by the supplier.
The results were normalized to the total
intracellular protein content determined by the BCA Protein Assay Kit (Pierce, Thermo Fisher, USA) and expressed as nmol/min/mg protein.
2.8 Viability and osteogenic behavior of hBMSCs 2.8.1 Cell culture The hBMSCs obtained from ATCC were maintained in αMEM (Hyclone) supplemented with 10% FBS (Corning) and 1% penicillin-streptomycin (Invitrogen).
The
cells were incubated in a humidified atmosphere of 5% CO2 at 37 °C and the medium were refreshed every other day.
Unless stated otherwise, the hBMSCs were seeded on the
samples with a density of 2 × 104 cells/well using 24-well TCP as the holders.
15
For
osteogenic induction, the hBMSCs seeded onto different samples were allowed to proliferate for 3 days and the medium was further supplemented with 50 µg/ml ascorbic acid 2 phosphate, 10 mM β-glycerophosphate, and 10 nM dexamethasone.
2.8.2 Proliferation and osteogenic differentiation of hBMSCs
The cell morphology was observed by FE-SEM after culturing for 24 hours.
At least 12
randomly selected areas per sample were examined from three independent experiments and the representative images were shown.
All the images were analyzed by ImageJ software to
quantitatively compare the coverage of hBMSCs on the different samples.
Cell proliferation
was determined by the CCK-8 assay after culturing for 1, 3, and 5 days.
The ALP activities
were evaluated after osteogenic induction for 3, 7, and 14 days.
These assays were
performed per the protocols mentioned in the above sections.
The gene expressions of ALP,
type-1 collagen (COL), osteocalcin (OCN), and runt-related transcription factor 2 (Runx2) after osteogenic induction of hBMSCs for 7 and 14 days were analyzed by RT-PCR.
The
forward and reverse primers are listed in Table S2.
2.8.3 Collagen secretion
The sirius red staining assay was performed to evaluate collagen secretion from hBMSCs to the surfaces.
After osteogenic induction for 14 and 21 days, the cells were fixed with 4%
paraformaldehyde for 30 minutes and stained with Picro sirius red stain Kit (Solarbio, China), which contained 0.1% sirius red in a saturated picric acid solution, for 2 hours.
The
unbound stain was removed by rinsing with 0.1 M acetic acid thoroughly and observed by optical microscopy.
In the quantitative assay, the remaining stain on the samples was eluted 16
in a destaining solution (0.2 M NaOH/methanol 1:1) and the absorbance was measured at 570 nm on the microplate reader.
2.8.4 ECM mineralization
The degree of extracellular matrix (ECM) mineralization was evaluated by alizarin red S staining.
After osteogenic induction for 14 and 21 days, the cells on the surfaces were fixed
with 75% ethanol for 1 hour and stained with 1% alizarin red S solution (pH = 4.2, Solarbio, China) at room temperature for 30 minutes.
The unbound stain was removed by rinsing with
distilled water and observed by optical microscopy.
In the quantitative assay, the bound
stains were eluted with 500 µl/well of 10% cetylpyridinium chloride in 10 mM sodium phosphate and the OD values of the solution were measured at 570 nm.
2.9 In vivo evaluation 2.9.1 Surgical procedure
The animal procedures and experiments were approved by the Ethics Committee for Animal Research, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences.
The 12 weeks old female Sprague Dawley rats with a mean body weight of 350 g
were used in this study.
After general anesthesia, the distal aspects of the femurs were
carefully exposed via skin incision and muscle blunt dissection. mm was drilled longitudinally into the distal femurs.
A hole with a diameter of 2
PEEK, O2, and PH1.8 rods (Φ 2 mm ×
7 mm) were then randomly implanted in the bilateral femurs of the rats.
The contingent
gaps were padded with bone wax and the surgical sites were then carefully closed in layers.
17
8 weeks after surgical operation, the bilateral femurs containing cylindrical implants were harvested from the sacrificed rats and fixed in 4% polyformaldehyde.
2.9.2 Sequential Fluorescent Labeling
The new bone formation and mineralization process around the implant rods was evaluated by the polychrome sequential fluorescent labeling assay.
At 2, 4, and 6 weeks
post implantation, 3 different fluorochromes were intraperitoneally administered into the rats at a sequence of 30 mg/kg alizarin red S, 25 mg/kg tetracycline hydrochloride, and 20 mg/kg calcein, respectively.
2.9.3 Micro-CT evaluation
The newly formed bone around the implants was detected and imaged using Micro-CT (Quantum FX, PerkinElmer). program (SkyScan).
After scanning, the 3D images were reconstructed with CTvol
A hollow cylinder with the thickness of 120 µm from the implant
surface and length of middle 5 mm of the implant (1 mm each away from the implant ends) was defined as the volume of interest for analysis.
The bone volume/total volume (BV/TV),
trabecular thickness (Tb.Th), trabecular number (Tb.N), and trabecular separation (Tb.Sp) were determined by 3D bone morphometric analysis.
2.9.4 Histological evaluation
After Micro-CT scanning, the fixed femur specimens were dehydrated in a graded series of ethanol, embedded in polymethylmetacrylate, and cut into longitudinal sections with a thickness of 100 µm using a Exakt system (310 CP, Exakt).
18
The sections were subsequently
ground and polished to a final thickness of about 50 µm for histological evaluation. Fluorescence observation was performed under a confocal laser scanning microscope (TCS SP8, Leica, Germany).
The excitation/emission wavelengths used to observe the chelating
fluorochromes were 543/620 nm, 405/575 nm and 488/520 nm for alizarin red S (red), tetracycline hydrochloride (yellow), and calcein (green), respectively.
Afterwards, the
sections were stained by Van Gieson’s picrofuchsin to visualize the bone-implant interfaces.
2.10 Statistical analysis
All the experiments were performed at least in triplicate and the results were presented as mean ± standard deviation.
One-way analysis of variance (ANOVA) followed by
Student-Newman-Keuls post hoc test was performed to determine the statistical significance. A difference at *p < 0.05 was considered to be significant and that at
**
p < 0.01 was
considered to be highly significant.
3. Results
3.1. Surface characterization
The PEEK specimens with different surfaces are prepared as shown in Fig. 1.
The
PEEK samples are first treated with an O2 plasma and then thin films with nanoporous structures are fabricated by the LBL technique followed by immersion in aqueous solutions and thermal cross-linking.
The samples are designated as O2 (O2 plasma treatment only),
PH1.8, and PH2.4 (1.8 and 2.4 are the solution pH values and please refer to the experimental 19
section for more details).
There is very little visual difference among the samples from the
top but the oblique views of PH1.8 and PH2.4 show light blue and yellow tinges, respectively (Fig. 2a).
According to the FE-SEM observation shown in Fig. 2b, scratches resulting from
sandpaper grinding are clear on the pristine PEEK and the O2 surface shows additional features arising from O2 plasma etching.
After deposition of LBL films, both PH1.8 and
PH2.4 exhibit homogeneous surfaces without scratches and the high-resolution images disclose nanoporous structures.
The pore size of PH1.8 is several tens of nanometers and
that of PH2.4 is in the range of 200 - 500 nm.
These topographical features are confirmed
by AFM (Fig. S2) and the surface roughness follows the order of O2 > PEEK > PH2.4 > PH1.8.
According to the cross-sectional SEM images in Fig. S3, the thickness of the PH1.8
film is about 120 nm and that of the PH2.4 film is about 200 nm. Fig. 2c shows the survey XPS spectra and the atomic percentages are presented in Fig. 2d.
Only the C 1s and O 1s peaks are detected from PEEK while the N 1s peak emerges
gradually from O2, PH1.8, and PH2.4.
O2 sample has the largest oxygen content and some
nitrogen is introduced because the active radicals generated during the O2 plasma treatment react with atmospheric oxygen and nitrogen after air exposure [35].
According to the fitted
high-resolution spectra (Fig. S4), the O 1s peak can be deconvoluted into three components at 531.2 eV, 532.2 eV, and 533.3 eV, corresponding to O=C, O-H, and O-C, respectively. particular, the larger O-H peak on O2 contributes to better wettability.
In
In the N 1s spectra,
the peak at 401 eV corresponding to amide bonds (N-C=O) is found from PH1.8 and PH2.4, confirming crosslinking between the carboxylate and amine groups after the 180 °C heat treatment.
Additionally, the spectra of PH1.8 and PH2.4 are quite similar and the similar
20
O/C and N/C ratios (Table S3) indicate that different post-treatment only affects the surface topography but not the surface chemistry. The surface hydrophilicity of the samples is evaluated by static contact angle measurement.
As shown in Fig. 2e, the water contact angle of pristine PEEK is 87.6° and
decreases to 32.0° after the O2 plasma treatment. A slight increase in the water contact angle is observed after deposition of the LBL films.
The changes in water wettability stem from
the variation of surface functional polar groups as shown by the XPS spectra and different topographies.
Since PH1.8 and PH2.4 show similar surface chemistry, the difference in
contact angles can be ascribed to the changes in the surface roughness. The zeta potentials are determined to investigate the electrical state on the samples, which significantly influence the biological responses. show descending zeta potentials with increasing pH.
As shown in Fig. 2f, the surfaces At a pH of 7.4 similar to that of the
physiological environment, the zeta potentials follow the order of PH1.8 > O2 > PH2.4 > PEEK.
21
Fig. 2.
Characterization of different samples: (a) Photographs taken from the top and an
oblique angle; (b) SEM images; (c) XPS survey spectra; (d) Atomic ratios; (e) Water contact angles; (f) Zeta potentials versus pH plots.
3.2 Film adhesion
The film adhesion strength is evaluated by nano-scratch tests by drawing a diamond indenter across the thin films under increasing normal loads. SEM images of the 50 µm scratch tracks.
Fig. 3 presents the panoramic
Without the pre-treatment of O2 plasma, the films
are readily damaged and delaminated once the indenter comes into contact with the surface and moves laterally (Figs. 3a and 3c).
A large area is scraped off from the film by the
moving stylus along the entire length of the scratch track.
In addition, cracks are visible
along the edges of the scratch track and they propagate a considerable distance to either side of the track.
At the end of the track, buckling and pile-up occur ahead of the indenter.
these observations indicate poor film adhesion.
All
As for PH1.8 and PH2.4 surfaces, plastic
deformation (plowing) is observed at a small load (Fig. 3b and 3d).
Delamination then
occurs after the indenter moves about 4.33 µm and 3.18 µm on PH1.8 and PH2.4 (marked by the red dotted lines), corresponding to normal loads of 0.87 mN and 0.63 mN, respectively. However, spallation after scratching is not conspicuous and generally confined within the scratch track and the edges of the tracks on PH1.8 and PH2.4 maintain the integrity without distortion.
No cracks are visible along the edges of the tracks on PH1.8, whereas minor
cracks without propagation are observed from PH2.4. 22
The plowed regions can also be found
from the track of PH1.8, indicating that the adhesion strength is even better than the cohesive strength of the film.
Fig. 3.
Panoramic SEM images of the nanoscratch test tracks after loading with the sliding
direction from left to right: (a) PH1.8 and (c) PH2.4 films fabricated on PEEK without the pretreatment of O2 plasma; (b) PH1.8 and (d) PH2.4 films fabricated on PEEK following the procedures shown in Fig. 1.
23
3.3 Acute inflammatory response of RAW264.7
The murine macrophage cell line RAW264.7 is used to evaluate the acute inflammatory response on the different samples and the 24-well TCP, and TCP with 10 ng/ml lipopolysaccharides supplemented in the culture medium (denoted as LPS) are employed as the negative and positive controls, respectively. h is examined by FE-SEM (Fig. 4a).
The cell morphology after incubation for 24
The cells on PEEK have a flattened appearance and the
cytoplasmic protrusions spread across the surface.
Spindle-shaped macrophages with
numerous protrusions are observed from O2 sample, whereas those on PH1.8 and PH2.4 display a normal spherical shape and low spreading with only a few pseudopodia.
For
comparison, the macrophages on the TCP surface have a round appearance with weak filopodial attachments, whereas under stimulation of lipopolysaccharides, they exhibit an irregular shape and extended pseudopodia. Proliferation of macrophages after culturing on for 1 and 3 days is assessed by the CCK-8 assay.
As shown in Fig. 4b, the PEEK group exhibits the highest rate of cell
proliferation at both time points.
The O2 surface slightly inhibits proliferation after the first
day but the difference disappears after 3 days.
Significantly lower cell proliferation is
observed from PH1.8 and PH2.4 than PEEK, while the difference is not significant in comparison with the negative TCP control. To evaluate the effects of different surfaces on macrophage polarization, the gene expression of function-associated markers of M1- and M2-type macrophages after culturing for 1, 3, and 5 days is determined by RT-PCR.
The results are presented as a heat map in
Fig. 4c with the original quantification data provided in Fig. S5. 24
The fold changes in gene
expressions are normalized to those of PEEK and the TCP and LPS groups are shown for reference.
The iNOS and pro-inflammatory cytokines such as TNF-α, IL-6, and IL-1β are
referred to as the M1-related genes, while the CD206, and anti-inflammatory growth factors including TGF-β1, BMP-2, and VEGF are considered as the M2-related genes.
All four
kinds of M1 gene expressions, except IL-6 at day 1, are notably down-regulated on PH1.8 and PH2.4 in the first 3 days.
The fold changes in the M1 gene expressions are comparable or
even lower than those of TCP.
When the culturing time is extended to 5 days, the PH1.8 and
PH2.4 groups still show significant down-regulation of the iNOS and TNF-α levels.
These
results indicate that the functionalized surfaces inhibit early pro-inflammatory M1 polarization of macrophages.
With regard to the M2-related genes, the expression levels of
the canonical M2 marker CD206 are up-regulated on the modified surfaces at all 3 time points. In particular, after culturing for 5 days, the gene expression of CD206 on PH1.8 is four times higher than that on PEEK.
The expression of other M2-related genes like TGF-β1, BMP-2,
and VEGF are also significantly up-regulated after culturing the macrophages on PH1.8 and PH2.4 for 5 days, implying that the functionalized surfaces not only facilitate the switch of macrophages to the M2 phenotype, but also induce secretion of anti-inflammatory growth factors as the culture time is increased.
The results demonstrate that polarization of
macrophages on samples is modulated in a time-dependent manne and the fabricated films, particularly those on PH1.8, possess the ability to inhibit early pro-inflammatory M1 polarization and promote the expression of M2-related gene with prolonged culture time. Fig. 4d shows the secretion of extracellular pro-inflammatory cytokines TNF-α determined by ELISA after culturing the macrophages for 3 days.
25
As expected, release of
TNF-α is greatly suppressed on PH1.8 and PH2.4 and there is no significant difference in TNF-α secretion between the PH1.8 group and TCP control.
The other cytokines such as
pro-inflammatory cytokines IL-6 and IL-1β as well as the anti-inflammatory cytokine IL-4 and interleukin 10 (IL-10) are further measured but their concentrations in the supernatant are below the detection limit (results not shown).
The NO production by macrophages after 3
days culture is also evaluated and the results show that the NO contents are lower on all the modified samples (Fig. S6).
The ROS results provided by flow cytometric analysis reveal
that the proportion of ROS positive cells decreases from 35.7% on PEEK to 24.4% on O2 sample, while PH1.8 and PH2.4 further reduce the level to 15.7% and 19.6%, respectively (Fig. S7).
The osteoclastogenic differentiation of RAW264.7 cells is detemined by the
TRAP assay which shows that osteoclast formation on PH1.8 and PH2.4 is suppressed (Fig. 4e).
Interestingly, the TCP group does not show significant inhibitory effects on the TRAP
activity in comparison with the PEEK group.
26
Fig. 4.
Acute inflammatory response of RAW264.7 on different samples: (a) SEM images
showing the cell morphology after culturing for 24 hours; (b) Cell proliferation determined by the CCK-8 assay after incubation for 1 and 3 days; (c) Heat map depicting the expression of the M1- and M2-related genes based on the RT-PCR results after incubation for 1, 3, and 5 days;
(d) TNF-α level in the supernatant after culturing for 3 days; (e) TRAP activity after
culturing for 8 days.
p < 0.05, **p < 0.01.
*
3.4 Whole genome expression analysis
To elucidate the mechanisms why macrophages respond differently on the different surfaces, the whole genome expression analysis is performed after the macrophages are cultured on the pristine PEEK and PH1.8 for 3 days. 27
Of the total 22,206 genes analyzed,
2,815 differentially expressed genes are identified between PEEK and PH1.8 (Fig. S8). Then GO analysis is performed to characterize the physiological significance of these changes. The primary down-regulated Biological Process category involves terms like “cell adhesion”, “regulation of cell proliferation”, “innate immune response”, “inflammatory response”, “immune system process”, and “positive regulation of ROS metabolic process” (Table S4), which are in full agreement with the observed cellular response in vitro.
Meanwhile, the
Cellular Component category, which indicates the locations in the macrophages where the regulated gene products perform the functions [36], are mainly associated with the plasma membranes (Table S5).
The regulated genes are also enriched into the pathways according
to the KEGG database (Table S6).
The pathway-act network (Fig. S9) is subsequently
constructed and the top 10 signaling pathways with high degree centrality are listed in Table S7.
The most significant interactions are related to the mitogen-activated protein kinase
(MAPK) and phosphoinositide 3-kinase/protein kinase B (PI3K-Akt) signaling pathways.
3.5 Osteogenic differentiation of hBMSCs induced by THP-1 macrophages
To facilitate homologous interactions, human monocytic THP-1 cells instead of RAW264.7 are adopted to study the effects of the macrophage conditioned medium on osteogenic differentiation of hBMSCs.
The THP-1 derived macrophages in the resting state
are obtained following the procedures illustrated in Fig. 5a.
The proinflammatory cytokine
TNF-α released into the culture medium by induced macrophages is examined using ELISA. Fig. 5c shows that secretion of TNF-α on all the modified samples is suppressed in comparison with the PEEK control.
The magnitude of the suppression effects is similar to
28
that of RAW264.7 as shown in Fig. 4d, indicating the consistency of macrophage response to the various samples between THP-1 derived macrophages and RAW264.7.
The conditioned
medium from the THP-1 derived macrophages is collected daily and supplied to hBMSCs every two days following the protocols described in Fig. 5b.
Subsequently, the ALP activity,
an early osteogenic differentiation marker of hBMSCs, is examined.
As shown in Fig. 5d,
the TCP group shows the highest ALP activity, followed by the PH1.8 and PH2.4 groups, with inferior ALP levels detected from the PEEK and O2 samples.
Hence, the macrophages
in contact with PH1.8 and PH2.4 create a more favorable microenvironment for osteogenic differentiation of hBMSCs than the PEEK and O2 groups.
29
Fig. 5.
Experimental design and analysis strategy: (a) Differentiation of THP-1 in the
macrophages; (b) Effects of the macrophage-conditioned medium on osteogenic differentiation of hBMSCs; (c) TNF-α secretion level of THP-1 derived macrophages in supernatant;
(d)
Normalized
ALP
activity
macrophage-conditioned medium for 3 and 7 days.
of
hBMSCs
cultured
in
the
p < 0.05, **p < 0.01.
*
3.6 Osteogenesis of hBMSCs
In vitro osteogenesis of hBMSCs cultured on the different samples is evaluated in terms of the cell morphology, proliferation, osteogenic gene expression, ALP activity, collagen secretion, as well as ECM mineralization.
As shown in Fig. 6a, slender cells with an
elongated shape are observed from the PEEK sample indicative of poor spreading.
The cells
cultured on O2 sample show better spreading but still attach poorly with few pseudopodia extensions.
In comparison, the cells on PH1.8 and PH2.4 are much more extended and have
a polygonal geometry.
The images with higher magnification disclose abundant filopodia
extending from the leading edges, indicating that they attach closely to the samples. According to the statistical analysis, the coverage of hBMSCs on PH1.8 and PH2.4 is significantly larger than that on PEEK and O2 (Fig. S10).
The time-dependent cell
proliferation is measured by the CCK-8 assay as shown in Fig. 6b.
There is no obvious
difference among the groups at day 1, but after 3 days, all the modified samples and TCP control show significantly better cell proliferation than PEEK. except that the O2 group falls behind.
This trend coninues to day 5
The hBMSCs cultured on the various samples after
30
osteogenic induction for 7 and 14 days are assessed for the expression of osteogenic genes including ALP, COL, OCN, and Runx2 as shown in Fig. S11.
Generally, the PH1.8 group
shows higher expressions of all the genes at both time points.
Subsequently, the ALP
activity of hBMSCs is evaluated after osteogenic induction for 3, 7, and 14 days.
Fig. 6c
shows that compared with PEEK, the O2 group slightly up-regulates the ALP activities, which are further enhanced on PH1.8 and PH2.4. day 14 is even higher than that of TCP.
The ALP activity of hBMSCs on PH1.8 at
Collagen secretion of the hBMSCs and the
corresponding staining images are displayed in Fig. 6d and Fig. 6f, respectively.
The
secreted collagen is denser on PH1.8 and PH2.4 than that on PEEK and O2 at both time points, and it is even comparable to the collagen secretion level of TCP.
Meanwhile, the
results of ECM mineralization based on alizarin red S staining shows a similar trend.
Fig. 6e
and Fig. 6g show more pronounced mineralized nodules on PH1.8 and PH2.4 than the PEEK and O2 groups and there is no statistical significance in ECM mineralization between the PH1.8 group and TCP control.
31
Fig. 6.
Osteogenic ability of hBMSCs cultured on different samples:
(a) SEM images (200
×, 500 ×, and 2000 × magnifications) showing the cell morphology after culturing for 24 hours with the cells at higher magnification shown with a pseudo green color; (b) Cell proliferation determined by the CCK-8 assay after incubation for 1, 3, and 5 days; (c) Normalized ALP activity after osteogenic induction for 3, 7, and 14 days; (d) Quantitative results and (f) Corresponding images of collagen secretion stained by sirius red after osteogenic induction for 14 and 21 days; (e) Quantitative results and (g) Images of extracellular matrix mineralization stained by alizarin red S after osteogenic induction for 14 and 21 days.
p < 0.05, **p < 0.01.
*
32
3.7 In vivo assays of osseointegration
Based on the superior performance observed in vitro, PH1.8 is selected as the representative sample for in vivo evaluation.
The reconstructed transverse, sagittal, coronal,
and 3D micro-CT images demonstrate that thin bone layers are formed around the implants within cancellous bone after implantation for 8 weeks.
The bone volume is visually larger
surrounding the PH1.8 implants (Fig. 7a) and quantitative analysis shows that both the bone volume ratio (Fig. 7b) and trabecular numbers (Fig. 7d) are highest for the PH1.8 group.
In
addition, although there is no significant difference in the trabecular thickness among the groups (Fig. 7c), a notable decrease in trabecular separation (Fig. 7e) which corresponds to the distance between adjacent trabecula is observed from the PH1.8 group.
The results
indicate that the quality and quantity of newly formed bone surrounding the PH1.8 implants are drastically better than those of the PEEK and O2 groups. The process of new bone formation surrounding the three kinds of implants is monitored by sequential fluorescent labeling.
As shown in Figs. 7f and 7g, the fluorescent
areas follow the order of PH1.8 (4.20 ± 0.46%) > O2 (2.33 ± 0.55%) ≈ PEEK (2.26 ± 0.36%), indicating that PH1.8 is more effective in facilicating bone deposition and remodeling than the other samples at each time point.
Fig. 7h shows the histological sections of different
experimental groups after being stained by van Gieson’s Picrofuchsin. layers can be observed from the peri-implant.
Newly formed bone
However, fibrous connective tissues are
observed from the bone-implant interface with PEEK (red arrows) and the bone layer in contact with O2 is discontinuous (yellow arrows).
In contrast, the PH1.8 group shows a
great degree of continuous bone apposition which bonds directly with the surface (white 33
arrows) and a few fibrous connective tissues (red arrow) are observed.
According to the
quantitative analysis shown in Fig. 7i, the PH1.8 group has a significantly higher percentage of bone-implant contact than the PEEK and O2 groups, thereby corroborating the superior ability in promoting osseointegration.
Fig. 7.
In vivo osseointegration of different implants: (a) Reconstructed transverse, sagittal,
coronal, and 3D Micro-CT images; (b-e) Quantitative analysis of Micro-CT data including (b) BV/TV, (c) Tb.Th, (d) Tb.N and (e) Tb.Sp; (f) Sequential fluorescent labeling of new bone formation [Red, yellow, and green represent labeling by alizarin red S (week 2), tetracycline hydrochloride (week 4), and calcein (week 6), respectively]; (g) Histogram of percentages of the areas of fluorochromes stained bone; (h) Histological observations of the tissue sections stained with Van Gieson’s picrofuchsin [Images at 100 × magnification are taken from yellow rectangular marked areas of images at 40 × magnification, white arrows mark the direct 34
contact between implants and new bones, and red and yellow arrows indicate the area covered with fibrous tissue and discontinuous bone layer, respectively]; (i) Histogram of percentages of the bone-implant contact ratios.
4. Discussion
PEEK offers a set of characteristics superior to metallic implants in dental and orthopedic fields.
However, its wide application is limited by its inert surface properties
which elicit detrimental host immune response resulting in the formation of fibrous encapsulation.
Therefore, surface modification of PEEK to endow it with the
immunomodulatory ability to provide a favorable environment for implant-bone integration is of great interest.
LBL self-assembly is selected here as it is a versatile technique for
fabrication of multilayered films even on substrates with a complex geometry [28].
In fact,
LBL self-assembly has been adopted in various biomedical applications [29] such as drug delivery [30], tissue engineering [37], and biosensors [38].
In this study, the LBL technique
is utilized to develop a reliable and cost-effective method to construct well-adhered films on PEEK with predesigned immunomodulatory ability. Prior to film deposition, the surface of pristine PEEK is treated by an O2 plasma to produce better surface wettability (Fig. 2e) and negative surface charges (Fig. 2f).
Then
LBL assembled multilayers are deposited by alternately dipping the pre-treated substrates into weak polyelectrolyte solutions of PAH and PAA and ionization is pH-dependent thus facilitating subsequent acid-induced formation of the nanoporous structures. 35
In order to
improve the processing efficiency, the dipping time for each layer is only 1 minute compared to 15 minutes or even longer per step reported in the literature [39,40].
The shorter dipping
time also suppresses interlayer diffusion to reduce the film thickness [41]. After deposition, the scratches on pristine PEEK are concealed giving rise to a smooth surface which is featureless under SEM observation (Fig. S12).
However, from the perspective of cellular
response, biomaterials with the nanoscale surface topography can better guide cell functions by resembling the natural ECM for cell residing and interaction [42]. film with porous structures is desirable.
In this regard, the LBL
A multilayered film is assembled by electrostatic
attractions between the cationic NH4+ of PAH chains and anionic COO- of PAA chains.
If
the deposited films are exposed to acid solutions, the interchain ionic bonds will be partially cleaved due to the protonation of carboxylate groups and charge repulsion among the free and positively charged amine groups.
Consequently, rearrangement of the polymer chains is
induced by the post-treatments of acid solutions allowing dramatic swelling of the multilayers forming pores in the LBL films [43].
In our study, the LBL films soaked in solutions with
pH ranging from 2.6 to 2.0 for 30 seconds show surface holes and pits, whereas the porous structure is homogenous after the treatment at a pH of 2.4 (Fig. S13). lower, the multilayers are completely dissolved (Fig. S13).
At a pH of 1.6 or
Although the LBL films exposed
to the pH 1.8 solution are quite flat, nanoscale pores emerge after immersion in water for 30 seconds and immediate drying (Fig. S14).
Formation of pores can be ascribed to the
re-protonation of carboxylate groups and reformation of electrostatic interactions in the films leading to recompression of the swollen films. Apatially inhomogeneous rejection of water during the compression process gives rise to the nanoporous structure after the films are dried
36
[44].
In conclusion, the emergence of nanopores can be attributed to the swelling and
deswelling of the LBL films due to protonation and deprotonation of the PAA acid groups [45].
The changes in the surface morphology after the post-treatment are also reflected by
the substantial changes in interference color in Fig. 2a. As aforementioned, the electrostatic interactions between polyelectrolytes in the LBL films are susceptible to the variation of ambient conditions such as the pH, ionic strength, and temperature.
For instance, the nanoporous structures in the LBL films vanish after
immersion in PBS for 12 hours (Fig. S15).
Therefore, in order to preserve the desirable
morphological features, the films treated at pH of 1.8 and 2.4 are thermally cross-linked at 180 °C for 2 hours to form amide bonds between the carboxylate and amine groups [46]. The amide bonds formed during the thermal treatment are confirmed by XPS (Fig. S4) and the porous structures are preserved (Fig. S16).
The long-term durability of the thermally
treated LBL films is corroborated by that little morphological change is observed after immersion in PBS for 7 days (Fig. S15).
Moreover, as a high-performance thermoplastic
polymer, PEEK has been reported to endure a temperature of up to 250 °C [1] and so the transient thermal treatment at 180 °C is not expected to degrade the mechanical properties of PEEK. Besides the stability, the adhesion strength of LBL films is a critical factor as the improvement of osseointegration will be meaningless if the film delaminates from the PEEK substrate.
Furthermore, film failure under physiological stress will release fragments and
debris to activate macrophages in the peri-prosthetic tissues and produce possible chronic inflammation and osteoclastogenesis [47, 48] and osteoresorption predominates over
37
peri-implant osteogenesis to increase the incidence of bone loss (osteolysis) and aseptic loosening [49].
In this respect, the O2 plasma pre-treatment yields much stronger film
adhesion and superior scratch and abrasion resistance (Fig. 3).
The plasma treatment not
only removes contaminants from the sample surface, but also leaves active sites at the substrate surface [50], either for further oxidation in the ambient atmoshpere (Fig. S3) or forming covalent bonds with the polyelectrolytes during LBL assembly [51]. adhesion strength of fabricated films is significantly improved.
As a result, the
In addition, the abrasion
resistance of PH1.8 is better than that of PH2.4 (Fig. 3), which can be ascribed to their difference in surface roughness (Fig. S2) [52].
All in all, the LBL films fabricated following
the procedures shown in Fig. 1, particularly the PH1.8 group, have superior adhesion strength as well as scratch and abrasion resistance. IMacrophages play a central role in orchestrating the innate immune response against implanted biomaterials [11].
Depending on the specific cytokine patterns and local
microenvironment, macrophages exhibit high levels of functional and phenotypic plasticity to regulate a complex cascade of events throughout the implant lifetime, including the host inflammatory response, wound healing process, as well as long-term integration and survival of
the
implants
[14].
Therefore,
designing
orthopedic
biomaterials
with
a
immunomodulatory surface is an innovative strategy to strengthen osseointegration of bone implants [20,53].
According to the macrophage morphology, proliferation, gene expression,
TNF-α secretion, NO production, and intracellular ROS content, PH1.8 and PH2.4 are effective in inhibiting the acute inflammatory response of macrophages.
As no exogenous
regulation factors are released, the different performance of macrophages can be ascribed
38
solely to the variation in the surface physicochemical properties which affect the amount, type, conformation, and orientation of proteins nonspecifically adsorbed on the surface [54].
The
anchored proteins are recognized by a repertoire of pattern recognition receptors expressed on the macrophage membrane followed by initiation of the innate immune response [55].
To
elucidate the underlying molecular mechanism, whole-genome expression and enriched signaling pathways are analyzed. Integrins are the primary adhesion receptors involved in macrophage adhesion and cytoskeletal remodeling [56] and they also mediate the inflammatory responses by activating signal transduction through focal adhesion and PI3K-Akt signaling cascades [57]. According to the whole-genome expression analysis, the lower expressions of integrin (ITG) subunits (α4, α5, αM, αX, αD, β2, and β7) and adhesion complexes (actinin, filamin, paxillin) on PH1.8 can explain why macrophages show a normal round shape on PH1.8 and cells with an elongated and spread morphology are observed from PEEK (Fig. 4a).
These
differences also translate into substantial downstream effects such as reduced proliferation of macrophages on PH1.8 (Fig. 4b).
In addition, the Toll-like receptor (TLR) signaling
pathway is downregulated on PH1.8 (Table S6).
It has been reported that macrophages
recognize synthetic biomaterials in a similar way as gram-negative bacteria or lipopolysaccharides via TLR [58-60].
PH1.8 is found to suppress the expression of
lymphocyte antigen 96 (MD-2), which is necessary for the response of TLR-4 to LPS, thus negatively regulating the TLR signaling pathway as well as downstream signaling cascades [61].
Besides integrins and TLR, the NOD-like receptor (NLR) signaling pathway is
involved in the recognition of PH1.8 surface (Table S6), although NLR is a cytoplasmic
39
receptor that senses intracellular cytosolic pathogens [62].
Downregulation of the NLR
signaling pathway is realized mainly by attenuating the activation of receptor-interacting protein 2 (RIP2). The attenuated focal adhesion, TLR, and NLR signaling pathways ultimately converge into downstream MAPK and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling cascades, resulting in reduced transcription of inflammation-related genes such as inducible nitric oxide synthase (NOS2), prostaglandin-endoperoxide synthase 2 (COX2), C-C motif chemokine ligand 3/4 (MIP-1α/β), and colony stimulating factor 1/2 (CSF1/2).
In particular, the gene expression of proinflammatory cytokines TNF-α is
suppressed on PH1.8 (Fig. 4c) and decreased secretion is confirmed by the ELISA results (Fig. 4d).
TNF-α together with other pro-inflammatory cytokines in turn triggers transient
activation of the TNF-α signaling pathway and JAK-STAT signaling pathway, which are also found to be downregulated on PH1.8 (Table S6 and S7) [63,64].
Therefore, it is reasonable
to hypothesize that the autocrine response of macrophage on PH1.8 falls into an attenuating feedback loop that gradually silences the acute inflammatory response.
This notion is
partially supported by the time-dependent changes in the expression of M1/M2 related genes (Fig. 4c).
The mechanism by which PH1.8 alleviates the acute inflammatory response is
illustrated in Fig. 8.
40
Fig. 8.
Schematic illustration of the key signaling transduction cascades on the PH1.8
sample in comparison with pristine PEEK.
The downregulated genes are highlighted in
green, and upregulated genes are highlighted in red and differentially expressed genes are screened by the whole genome expression analysis.
The signaling pathways are constructed
based on the KEGG database.
After resolving the acute inflammatory response at early stage, the LBL surfaces promote polarization of the macrophages into the M2 phenotype (Fig. 4c), which further possesses the ability to enhance osteogenic differentiation of hBMSCs by secreting a series of cytokines [65].
Therefore, the ALP activity of hBMSCs is enhanced after they are cultured
in the macrophage-conditioned medium collected from the LBL surfaces (Fig. 5d). Furthermore, macrophages fuse together and differentiate into osteoclasts as the culture time is increased.
As shown in Fig. 4e, the LBL surfaces exhibit inhibitory effects on
osteoclastogenesis thereby avoiding excessive bone resorption in early phase of bone 41
remolding [66].
All in all, the immune response of macrophages mediated by the LBL
surfaces synergistically contributes to upregulated osteogenesis and downregulated osteoclastogenesis which shows great potentialino facilitating peri-implant osseointegration. HBMSCs are another type of cells that play a critical role in osseointegration. Compared with the pristine PEEK and O2 samples, the LBL films provide more favorable milieus for hBMSCs adhesion, spreading (Fig. 6a), and proliferation (Fig. 6b).
The
hBMSCs cultured on the LBL films show a tendency of osteogenic differentiation as indicated by the enhanced ALP activity (Fig. 6c), improved collagen secretion and ECM mineralization (Fig. 6d-g), as well as numerous up-regulated osteogenic genes (ALP, COL, OCN, and RUNX2) (Fig. S7).
Besides the surface chemistry, these improvements can be
mainly ascribed to the porous structures constructed on the LBL films [67].
Osteoblasts
prefers rougher surfaces [68-70] and the topographical cues of orthopedic implants can be tailored to improve osseointegration [71,72].
Moreover, PH1.8 shows a superior osteogenic
ability than PH2.4 (Figs. 6c and 6e) and given the similar chemical composition, the difference in surface topography appears to be the main reason.
In fact, it has been reported
that surface nanoporous structures with a disordered arrangement, like that on PH1.8, deliver better performance than micrometer-scale features in promoting stem cell differentiation towards the osteogenic lineage [73,74].
Here, PEEK, O2, and PH1.8 are chosen for in vivo
evaluation of osseointegration and micro-CT, sequential fluorescent labeling, and histological analysis corroborate the in vitro findings revealing superior new bone formation without the presence of fibrous tissues for the PH1.8 group.
42
The comprehensive results provide
unambiguous evidence that LBL films with nanoporous structures provide a more promising milieu than pristine PEEK for better peri-implant osseointegration.
5. Conclusion
A reliable and cost-effective method to fabricate adherent films with tunable structures on PEEK is described.
The simplicity and reliability of this technique allows commercial
production on a large scale even for biomedical implants with a complex shape.
The in vitro
cellular response and in vivo osseointegration are investigated systematically.
The results
indicate that the LBL films, especially PH1.8 with a nanoporous structure, endow PEEK with immunomodulatory capability to inhibit the early acute inflammatory response of macrophages and induce macrophages to create a favorable microenvironment for osteogenesis.
This temporal response of macrophages is consistent with that in the natural
healing process of bone fracture.
In vivo results corroborate the improved osseointegration
on the functionalized PEEK sample.
Our findings provide not only new knowledge about
the regulation of the host immune response on biomaterials, but also insights into the design of high-performance implants for orthopedic applications.
Acknowledgements
The authors acknowledge financial support from the National Natural Science Foundation of China (No. 31922040), Shenzhen Science and Technology Research Funding 43
(No. JCYJ20180507182637685), Youth Innovation Promotion Association of Chinese Academy of Sciences (No. 2017416), Youth Talents of Guangdong Science and Technology Innovation (No. 2015TQ01C534), Leading Talents of Guangdong Province Program (No. 00201520), Shenzhen Peacock Program (No. KQTD2016030111500545), China Postdoctoral Science Foundation (No. 2018M631007), Science and Technology Service Network Initiative of Chinese Academy of Sciences (No. KFJ-STS-QYZX-035), Guangdong - Hong Kong Technology Cooperation Funding Scheme (TCFS) (No. GHP/085/18SZ), as well as Hong Kong Research Grants Council (RGC) (No. CityU 11205617).
Appendix A. Supplementary Data
Supplementary data related to this article can be found in the document named Supplementary Information.
Data availability
The data are available from the corresponding author on reasonable request.
References [1] S. M. Kurtz, J. N. Devine, PEEK biomaterials in trauma, orthopedic, and spinal implants, Biomaterials 28 (2007) 4845. [2] I. V. Panayotov, V. Orti, F. Cuisinier, J. Yachouh, Polyetheretherketone (PEEK) for
44
medical applications, J. Mater. Sci: Mater. Med. 27 (2016) 118. [3] Q. Chen, G. A. Thouas, Metallic implant biomaterials, Mater. Sci. Eng. R-Rep. 87 (2015) 1. [4] D. Almasi, N. Iqbal, M. Sadeghi, I. Sudin, M. R. A. Kadir, T. Kamarul, Preparation methods for improving PEEK’s bioactivity for orthopedic and dental application: a review, Int. J. Biomater. 2016 (2016) ID8202653. [5] R. Ma, T. Tang, Current strategies to improve the bioactivity of PEEK, Int. J. Mol. Sci. 15 (2014) 5426. [6] Y. Zhao, H. M. Wong, W. Wang, P. Li, Z. Xu, E. Y. Chong, C. H. Yan, K. W. Yeung, P. K. Chu, Cytocompatibility, osseointegration, and bioactivity of three-dimensional porous and nanostructured network on polyetheretherketone, Biomaterials 34 (2013) 9264. [7] L. Ouyang, Y. Zhao, G. Jin, T. Lu, J. Li, Y. Qiao, C. Ning, X. Zhang, P. K. Chu, X. Liu, Influence of sulfur content on bone formation and antibacterial ability of sulfonated PEEK, Biomaterials 83 (2016) 115. [8] J. Wen, T. Lu, X. Wang, L. Xu, Q. Wu, H. Pan, D. Wang, X. Liu, X. Jiang, In vitro and in vivo evaluation of silicate-coated polyetheretherketone fabricated by electron beam evaporation, ACS Appl. Mater. Interfaces 8 (2016) 13197. [9] M. Chen, L. Ouyang, T. Lu, H. Wang, F. Meng, Y. Yang, C. Ning, J. Ma, X. Liu, Enhanced bioactivity and bacteriostasis of surface fluorinated polyetheretherketone, ACS Appl. Mater. Interfaces 9 (2017) 16824. [10] J. M. Anderson, A. Rodriguez, D. T. Chang, Foreign body reaction to biomaterials, Semin. Immunol. 20 (2008) 86. [11] B. N. Brown, B. D. Ratner, S. B. Goodman, S. Amar, S. F. Badylak, Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine, Biomaterials 33 (2012) 3792. [12] R. Klopfleisch, Macrophage reaction against biomaterials in the mouse model– Phenotypes, functions and markers, Acta Biomater. 43 (2016) 3. [13] D. M. Mosser, J. P. Edwards, Exploring the full spectrum of macrophage activation, Nat. Rev. Immunol. 8 (2008) 958. [14] R. Sridharan, A. R. Cameron, D. J. Kelly, C. J. Kearney, F. J. O’Brien, Biomaterial based 45
modulation of macrophage polarization: a review and suggested design principles, Mater. Today 18 (2015) 313. [15] Z. Chen, T. Klein, R. Z. Murray, R. Crawford, J. Chang, C. Wu, Y. Xiao, Osteoimmunomodulation for the development of advanced bone biomaterials, Mater. Today 19 (2016) 304. [16] A. Vishwakarma, N. S. Bhise, M. B. Evangelista, J. Rouwkema, M. R. Dokmeci, A. M. Ghaemmaghami, N. E. Vrana, A. Khademhosseini, Engineering immunomodulatory biomaterials to tune the inflammatory response, Trends Biotechnol. 34 (2016) 470. [17] K. L. Spiller, S. Nassiri, C. E. Witherel, R. R. Anfang, J. Ng, K. R. Nakazawa, T. Yu, G. Vunjak-Novakovic, Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds, Biomaterials 37 (2015) 194. [18] A. Gao, R. Hang, W. Li, W. Zhang, P. Li, G. Wang, L. Bai, X Yu, H. Wang, L. Tong, Linker-free covalent immobilization of heparin, SDF-1α, and CD47 on PTFE surface for antithrombogenicity, endothelialization and anti-inflammation, Biomaterials 140 (2017) 201. [19] J. Lee, H. Byun, S. K. M. Perikamana, S. Lee, H. Shin, Current advances in immunomodulatory biomaterials for bone regeneration, Adv. Healthcare Mater. 8 (2019) 1801106. [20] Q Ma, L Zhao, R Liu, B. Jin, W. Song, Y. Wang, Y. Zhang, L. Chen, Y. Zhang, Improved implant osseointegration of a nanostructured titanium surface via mediation of macrophage polarization, Biomaterials 35 (2014) 9853. [21] S. N. Christo, A. Bachhuka, K. R. Diener, A. Mierczynska, J. D. Hayball, K. Vasilev, The role of surface nanotopography and chemistry on primary neutrophil and macrophage cellular responses, Adv. Healthcare Mater. 5 (2016) 956. [22] S. Dobbenga, L. E. Fratila-Apachitei, A. A. Zadpoor, Nanopattern-induced osteogenic differentiation of stem cells–A systematic review, Acta Biomater. 46 (2016) 3. [23] Y. Cheng, H. Yang, Y. Yang, J. Huang, K. Wu, Z. Chen, X. Wang, C. Lin, Y. Lai, Progress in TiO2 nanotube coatings for biomedical applications: a review, J. Mater. Chem. B 6 (2018) 1862. [24] K. S. Brammer, C. J. Frandsen, S. Jin, TiO2 nanotubes for bone regeneration, Trends 46
Biotechnol. 30 (2012) 315. [25] L. Wang, S. He, X. Wu, S. Liang, Z. Mu, J. Wei, F. Deng, Y. Deng, S. Wei, Polyetheretherketone/nano-fluorohydroxyapatite composite with antimicrobial activity and osseointegration properties, Biomaterials 35 (2014) 6758. [26] F. B. Torstrick, A. S. Lin, D. Potter, D. L. Safranski, T. A. Sulchek, K. Gall, R. E. Guldberg, Porous PEEK improves the bone-implant interface compared to plasma-sprayed titanium coating on PEEK, Biomaterials 185 (2018) 106. [27] T. Lu, X. Liu, S. Qian, H. Cao, Y. Qiao, Y. Mei, P. K. Chu, C. Ding, Multilevel surface engineering of nanostructured TiO2 on carbon-fiber-reinforced polyetheretherketone, Biomaterials 35 (2014) 5731. [28] J. Richardson, M. Björnmalm, F. Caruso, Technology-driven layer-by-layer assembly of nanofilms, Science 348 (2015) aaa2491. [29] R. R. Costa, J. F. Mano, Polyelectrolyte multilayered assemblies in biomedical technologies, Chem. Soc. Rev. 43 (2014) 3453. [30] S. Pavlukhina, S. Sukhishvili, Polymer assemblies for controlled delivery of bioactive molecules from surfaces, Adv. Drug Delivery Rev. 63 (2011) 822. [31] H. Zhang, K. Ren, H. Chang, J. Wang, J. Ji, Surface-mediated transfection of a pDNA vector encoding short hairpin RNA to downregulate TGF-β1 expression for the prevention of in-stent restenosis, Biomaterials 116 (2017) 95. [32] J. Chen, C. Howell, C. A. Haller, M. S. Patel, P. Ayala, K. A. Moravec, E. Dai, L. Liu, I. Sotiri, M. Aizenberg, J. Aizenberg, E. L. Chaikof, An immobilized liquid interface prevents device associated bacterial infection in vivo, Biomaterials 113 (2017) 80. [33] X. Zhu, X. J. Loh, Layer-by-layer assemblies for antibacterial applications, Biomater. Sci. 3 (2015) 1505. [34] K. Ren, M. Hu, H. Zhang, B. Li, W. Lei, J. Chen, H. Chang, L. Wang, J. Ji, Layer-by-layer assembly as a robust method to construct extracellular matrix mimic surfaces to modulate cell behavior, Prog. Polym. Sci. 92 (2019) 1. [35] M. M. Bilek, D. R. McKenzie, Plasma modified surfaces for covalent immobilization of functional biomolecules in the absence of chemical linkers: towards better biosensors and a new generation of medical implants, Biophys. Rev. 2 (2010) 55. 47
[36] M. Ashburner, C. A. Ball, J. A. Blake, D. Botstein, H. Butler, J. M. Cherry, A. P. Davis, K. Dolinski, S. S. Dwight, J. T. Eppig, M. A. Harris, D. P. Hill, L. Issel-Tarver, A. Kasarskis, S. Lewis, J. C. Matese, J. E. Richardson, M. Ringwald, G. M. Rubin, G. Sherlock, Gene ontology: tool for the unification of biology, Nat. Genet. 25 (2000) 25. [37] V. Gribova, R. Auzely-Velty, C. Picart, Polyelectrolyte multilayer assemblies on materials surfaces: from cell adhesion to tissue engineering, Chem. Mater. 24 (2011) 854. [38] R. M. Iost, F. N. Crespilho, Layer-by-layer self-assembly and electrochemistry: applications in biosensing and bioelectronics, Biosens. Bioelectron. 31 (2012) 1. [39] Q. Li, J. F. Quinn, F. Caruso, Nanoporous polymer thin films via polyelectrolyte templating, Adv. Mater. 17 (2005) 2058. [40] T. Boudou, T. Crouzier, K. Ren, G. Blin, C. Picart, Multiple functionalities of polyelectrolyte multilayer films: new biomedical applications, Adv. Mater. 22 (2010) 441. [41] J. Yu, B. M. Meharg, I. Lee, Adsorption and interlayer diffusion controlled growth and unique surface patterned growth of polyelectrolyte multilayers, Polymer 109 (2017) 297. [42] W. Chen, Y. Shao, X. Li, G. Zhao, J. Fu, Nanotopographical surfaces for stem cell fate control: Engineering mechanobiology from the bottom, Nano today 9 (2014) 759. [43] X. Chen, J. Sun, Fabrication of macroporous films with closed honeycomb‐ like pores from exponentially growing layer-by-layer assembled polyelectrolyte multilayers, Chem. Asian J. 9 (2014) 2063. [44] K. Chia, M. F. Rubner, R. E. Cohen, pH-responsive reversibly swellable nanotube arrays, Langmuir 25 (2009) 14044. [45] C. Sung, Y. Ye, J. L. Lutkenhaus, Reversibly pH-responsive nanoporous layer-by-layer microtubes, ACS Macro Lett. 4 (2015) 353. [46] W. Zhang, Q. Zhao, J. Yuan, Porous polyelectrolytes: the interplay of charge and pores for new functionalities, Angew. Chem. Int. Ed. 57 (2018) 6754. [47] T. Lin, Y. Tamaki, J. Pajarinen, H. A. Waters, D. K. Woo, Z. Yao, S. B. Goodman, Chronic inflammation in biomaterial-induced periprosthetic osteolysis: NF-κB as a therapeutic target, Acta Biomater. 10 (2014) 1. [48] C. Nich, Y. Takakubo, J. Pajarinen, M. Ainola, A. Salem, T. Sillat, A. Rao, M. Raska, Y. Tamaki, M. Takagi, Y. T. Konttinen, S. B. Goodman, J, Gallo, Macrophages - key cells in the 48
response to wear debris from joint replacements, J. Biomed. Mater. Res., Part A 101 (2013) 3033. [49] J. Gallo, S. B. Goodman, Y. T. Konttinen, M. A. Wimmer, M. Holinka, Osteolysis around total knee arthroplasty: a review of pathogenetic mechanisms, Acta Biomater. 9 (2013) 8046. [50] P. K. Chu, J. Y. Chen, L. P. Wang, N. Huang, Plasma-surface modification of biomaterials, Mater. Sci. Eng. R Rep. 36 (2002) 143. [51] F. Khelifa, S. Ershov, Y. Habibi, R. Snyders, P. Dubois, Free-radical-induced grafting from plasma polymer surfaces, Chem. Rev. 116 (2016) 3975. [52] B. D. Beake, A. J. Harris, T. W. Liskiewicz, Review of recent progress in nanoscratch testing, Tribology- Mater. Surf. Interfaces 7 (2013) 87. [53] Y. Shi, L. Wang, Y. Niu, N. Yu, P. Xing, L. Dong, C. Wang, Fungal component coating enhances titanium implant‐ bone integration, Adv. Funct. Mater. 28 (2018) 1804483. [54] I. Firkowska‐ Boden, X. Zhang, K. D. Jandt, Controlling protein adsorption through nanostructured polymeric surfaces, Adv. Healthcare Mater. 7 (2018) 1700995. [55] O. Takeuchi, S. Akira, Pattern recognition receptors and inflammation, Cell 140 (2010) 805. [56] A. L. Berrier, K. M. Yamada, Cell–matrix adhesion, J. Cell. Physiol. 213 (2007) 565. [57] A. S. Antonov, G. N. Antonova, D. H. Munn, N. Mivechi, R. Lucas, J. D. Catravas, A. D. Verin, αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt‐ dependent NF‐ κB activation, J. Cell. Physiol. 226 (2011) 469. [58] H. Zhou, K. Zhao, W. Li, N. Yang, Y. Liu, C. Chen, T. Wei, The interactions between pristine graphene and macrophages and the production of cytokines/chemokines via TLR-and NF-κB-related signaling pathways, Biomaterials 33 (2012) 6933. [59] T. H. Rogers, J. E. Babensee, Altered adherent leukocyte profile on biomaterials in Toll-like receptor 4 deficient mice, Biomaterials 31 (2010) 594. [60] J. Kzhyshkowska, A. Gudima, V. Riabov, C. Dollinger, P. Lavalle, N. E. Vrana, Macrophage responses to implants: prospects for personalized medicine, J. Leukoc. Biol. 98 (2015) 953. [61] S. Akira, S. Uematsu, O. Takeuchi, Pathogen recognition and innate immunity, Cell 124 (2006) 783. 49
[62] S. L. Demento, A. L. Siefert, A. Bandyopadhyay, F. A. Sharp, T. M. Fahmy, Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines, Trends Biotechnol. 29 (2011) 294. [63] T. Hanada, A. Yoshimura, Regulation of cytokine signaling and inflammation, Cytokine Growth Factor Rev. 13 (2002) 413. [64] N. Parameswaran, S. Patial, Tumor necrosis factor-α signaling in macrophages, Crit. Rev. Eukaryot. Gene Expr. 20 (2010) 87. [65] T. A. Wynn, K. M. Vannella, Macrophages in tissue repair, regeneration, and fibrosis, Immunity 44 (2016) 450. [66] R. J. Miron, D. D. Bosshardt, OsteoMacs: Key players around bone biomaterials, Biomaterials 82 (2016) 1. [67] M. S. Lord, M. Foss, F. Besenbacher, Influence of nanoscale surface topography on protein adsorption and cellular response, Nano Today 5 (2010) 66. [68] K. Metavarayuth, P. Sitasuwan, X. Zhao, Y. Lin, Q. Wang, Influence of surface topographical cues on the differentiation of mesenchymal stem cells in vitro, ACS Biomater. Sci. Eng. 2 (2016) 142. [69] X. Yao, R. Peng, J. Ding, Cell-material interactions revealed via material techniques of surface patterning, Adv. Mater. 25 (2013) 5257. [70] Y. Li, Y. Xiao, C. Liu, The horizon of materiobiology: a perspective on material-guided cell behaviors and tissue engineering, Chem. Rev. 117 (2017) 4376. [71] N. Gui, W. Xu, D. E. Myers, R. Shukla, H. P. Tang, M. Qian, The effect of ordered and partially ordered surface topography on bone cell responses: a review, Biomater. Sci. 6 (2018) 250. [72] R. A. Gittens, R. Olivares-Navarrete, Z. Schwartz, B. D. Boyan, Implant osseointegration and the role of microroughness and nanostructures: lessons for spine implants, Acta Biomater. 10 (2014) 3363. [73] W. L. Murphy, T. C. McDevitt, A. J. Engler, Materials as stem cell regulators, Nat. Mater. 13 (2014) 547.
50
[74] M. J. Dalby, N. Gadegaard, R. Tare, A. Andar, M. O. Riehle, P. Herzyk, C. D. W. Wilkinson, R. O. C. Oreffo, The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder, Nat. Mater. 6 (2007) 997.
51
All authors have read and approved the manuscript and it has not been submitted to another journal for publication. We declare that there is no conflict of interest.
Paul K Chu